You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Asthma control cost-utility randomized trial evaluation (ACCURATE): the goals of asthma treatment
|
|---|---|
| Published in |
BMC Pulmonary Medicine, November 2011
|
| DOI | 10.1186/1471-2466-11-53 |
| Pubmed ID | |
| Authors |
Persijn J Honkoop, Rik JB Loymans, Evelien H Termeer, Jiska B Snoeck-Stroband, Moira J Bakker, Willem JJ Assendelft, Peter J Sterk, Gerben ter Riet, Tjard RJ Schermer, Jacob K Sont |
| Abstract |
Despite the availability of effective therapies, asthma remains a source of significant morbidity and use of health care resources. The central research question of the ACCURATE trial is whether maximal doses of (combination) therapy should be used for long periods in an attempt to achieve complete control of all features of asthma. An additional question is whether patients and society value the potential incremental benefit, if any, sufficiently to concur with such a treatment approach. We assessed patient preferences and cost-effectiveness of three treatment strategies aimed at achieving different levels of clinical control:1. sufficiently controlled asthma2. strictly controlled asthma3. strictly controlled asthma based on exhaled nitric oxide as an additional disease marker |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 25% |
| United States | 1 | 25% |
| Ecuador | 1 | 25% |
| Argentina | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| India | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 97 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 18 | 18% |
| Student > Ph. D. Student | 15 | 15% |
| Researcher | 15 | 15% |
| Student > Master | 14 | 14% |
| Student > Bachelor | 10 | 10% |
| Other | 13 | 13% |
| Unknown | 16 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 38 | 38% |
| Nursing and Health Professions | 9 | 9% |
| Social Sciences | 7 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 6% |
| Psychology | 5 | 5% |
| Other | 13 | 13% |
| Unknown | 23 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 November 2011.
All research outputs
#13,358,186
of 22,659,164 outputs
Outputs from BMC Pulmonary Medicine
#736
of 1,891 outputs
Outputs of similar age
#146,227
of 239,474 outputs
Outputs of similar age from BMC Pulmonary Medicine
#6
of 13 outputs
Altmetric has tracked 22,659,164 research outputs across all sources so far. This one is in the 39th percentile – i.e., 39% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,891 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,474 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.